In 2026, the focus has moved toward GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-dependent Insulinotropic Polypeptide) receptor agonists
PREOPERATIVE RECOMMENDATIONS FOR GLP-1 RA MANAGEMENT PREOPERATIVE RECOMMENDATIONS FOR GLP-1 RA MANAGEMENT The ASA and the British Journal of Anaesthesia (BJA) published clinical recommendations in 2023 and 2024, respectively, addressing the perioperative management of patients treated with GLP-1 RAs [4,5]
At the core of GLP-1 Formula is dihydroberberine (DHB), a highly bioavailable form of berberine known for its ability to support healthy blood sugar metabolism and insulin sensitivity
blocking mitophagy with agents such as chloroquine sensitizes DTPs to MAPK inhibitors and delays recurrence
The reading is reported in percent weight on the Certificate of Analysis and confirms the expected 15.8% theoretical copper content for the 1:1 complex within tolerance
Garduo-Jimnez AL, Carter LJ